Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
14.70
-0.21 (-1.41%)
At close: Jun 26, 2025, 3:59 PM
14.79
0.61%
After-hours: Jun 26, 2025, 04:10 PM EDT
-1.41% (1D)
| Bid | 13.94 |
| Market Cap | 212.8M |
| Revenue (ttm) | 200K |
| Net Income (ttm) | 1.72B |
| EPS (ttm) | 119.02 |
| PE Ratio (ttm) | 0.12 |
| Forward PE | -1.6 |
| Analyst | n/a |
| Ask | 16.44 |
| Volume | 63,479 |
| Avg. Volume (20D) | 104,945 |
| Open | 14.56 |
| Previous Close | 14.91 |
| Day's Range | 14.44 - 14.77 |
| 52-Week Range | 10.80 - 17.79 |
| Beta | -0.28 |
About INBX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INBX
Website n/a
1 month ago
+10.89%
Inhibrx Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
7 months ago · seekingalpha.com
Inhibrx Biosciences: Reincorporated And Trying To Find A Niche With Unique PlatformINBX's two main pipeline candidates, INBRX-109 and INBRX-106, are entering critical late-stage trials with data readouts expected in mid- to late-2025. INBRX-109 targets DR5 in solid tumors, showing p...